Twist Bioscience Corp (TWST) insider buying and selling

NASDAQ: TWST · Source: SEC Form 4 filings · Latest trade reported

In the last 90 days at Twist Bioscience Corp (TWST), no insider made an open-market purchase and 8 insiders made 24 open-market sales worth $38.8M, as reported on SEC Form 4. All 24 sales were scheduled in advance or made to cover tax on vesting shares, so they say less about the insider's view of the stock. Over the last 12 months, 10 insiders sold $50.0M, of which $46.9M was scheduled or tax-related.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
24
$38.8M · 8 insiders
Insider buys, 12 months
0
$0 · 0 insiders
Insider sales, 12 months
59
$50.0M · 10 insiders

This is the public summary. Create a free account to see TWST’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock TWST

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

Open-market insider trades at Twist Bioscience Corp
DateInsiderTypeSharesPriceValue
Paula Green
SVP
Open market sale
2 trades
26,137avg. $81.67$2.1M
ROBERT F. WERNER
Chief Accounting Officer
Open market sale1,127$69.07$78K
JAN JOHANNESSEN
Director
Open market sale12,000$56.12$673K
ROBERT F. WERNER
Chief Accounting Officer
Open market sale4,961$56.88$282K

Scheduled and tax-related sales

Sales made under a pre-arranged 10b5-1 plan or to cover tax on vesting shares. They are listed separately because they are not a fresh decision to sell.

Scheduled and tax-related insider sales at Twist Bioscience Corp
DateInsiderTypeSharesPriceValue
Emily M. Leproust
CEO
10b5-1 sale
5 trades
41,570avg. $151.98$6.3M
ROBERT F. WERNER
Chief Accounting Officer
Sell to cover
2 trades
1,523avg. $140.02$213K
Emily M. Leproust
CEO
Sell to cover6,639$139.07$923K
Patrick John Finn
COO
Sell to cover4,046$139.07$563K
Adam Laponis
CFO
Sell to cover1,965$139.07$273K
Dennis Cho
See Remarks
Sell to cover1,598$139.07$222K
Paula Green
SVP
Sell to cover1,360$139.07$189K
Dennis Cho
See Remarks
10b5-1 sale14,205$129.75$1.8M

What the TWST insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for Twist Bioscience Corp and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with TWST Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about TWST insider trading

Who bought Twist Bioscience Corp (TWST) stock recently?

No insider made an open-market purchase of Twist Bioscience Corp (TWST) stock in the last 12 months.

Are insiders buying or selling TWST?

Over the last 12 months insiders were net sellers of TWST on discretionary trades: $0 bought against $3.2M sold (scheduled and tax-related sales excluded).

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see TWST in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.